UKUri Kartoun

Uri Kartoun

*This is an algorithmically generated author record based on publicly available information.

Uri Kartoun has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigating the impact of steroid dependence on gastrointestinal surgical outcomes from UK Biobank

    by Uri Kartoun, Akira Koseki, Akihiro Kosugi, Kingsley Njoku, Tesfaye Yadete, Eileen Koski, Joao Bettencourt-Silva, Natasha Mulligan, Jianying Hu, Julia Liu, et al.

    Although corticosteroids are an important treatment for inflammatory bowel disease (IBD) patients, many subjects develop dependence, leading to serious long-term side effects. We applied causal inference analyses to investigate the length of steroid use on reoperations in IBD patients. We identified subjects in the UK Biobank general practice dataset with at least one major GI surgery and followed them for at least 5 years to evaluate subsequent operations. We defined steroid dependence as at least 12 weeks of use (vs. acute steroid use) prior to baseline surgery. Of the 363 subjects included in our analyses, 163 (45%) were prescribed steroids on or before baseline surgery, and of these (N = 125 of 163, 77%) were dependent. Additional analyses for time-dependent data on prescriptions found a link between prescription length and reoperation. Among UC subjects with acute use, the odds of reoperation were significantly lower (OR: 0.32, 95% CI: 0.0–0.73). Steroid dependence resulted in a delay of reoperation (median 1.2 vs. 2.3 years, P = 0.01). Our findings indicate that long-term steroid use tends to increase the need for reoperation, whereas short-term use may reduce it.


  • Open Access

    Exploring the link between Gilbert’s syndrome and atherosclerotic cardiovascular disease: insights from a subpopulation-based analysis of over one million individuals

    by Uri Kartoun, Akl C Fahed, Shinwan Kany, Pulkit Singh, Shaan Khurshid, Aniruddh P Patel, Puneet Batra, Anthony Philippakis, Amit V Khera, Steven A Lubitz, et al.

    Uri Kartoun, PhD, Akl C Fahed, MD, MPH, Shinwan Kany, MD, Pulkit Singh, BA, Shaan Khurshid, MD, MPH, Aniruddh P Patel, MD, Puneet Batra, PhD, Anthony Philippaki


  • Open Access

    RMExplorer: A Visual Analytics Approach to Explore the Performance and the Fairness of Disease Risk Models on Population Subgroups

    by Bum Chul Kwon, Uri Kartoun, Shaan Khurshid, Mikhail Yurochkin, Subha Maity, Deanna G Brockman, Amit V Khera, Patrick T Ellinor, Steven A Lubitz, Kenney Ng

    Disease risk models can identify high-risk patients and help clinicians provide more personalized care. However, risk models developed on one dataset may not generalize across diverse subpopulations of patients in different datasets and may have unexpected performance. It is challenging for clinical researchers to inspect risk models across different subgroups without any tools. Therefore, we developed an interactive visualization system called RMExplorer (Risk Model Explorer) to enable interactive risk model assessment. Specifically, the system allows users to define subgroups of patients by selecting clinical, demographic, or other characteristics, to explore the performance and fairness of risk models on the subgroups, and to understand the feature contributions to risk scores. To demonstrate the usefulness of the tool, we conduct a case study, where we use RMExplorer to explore three atrial fibrillation risk models by applying them to the UK Biobank dataset of 445,329 individuals. RMExplorer can help researchers to evaluate the performance and biases of risk models on subpopulations of interest in their data.

  • Memory-memory (M2) Authentication

    by Uri Kartoun

    The article introduces a new type of an authentication technique denoted as memory-memory (M2). A core component of M2 is its ability to collect and populate a voice profile database and use it to perform the verification process. The method relies on a database that includes voice profiles in the form of audio recordings of individuals; the profiles are interconnected based on known relationships between people such that relationships can be used to determine which voice profiles to select to test a person’s knowledge of the identity of the people in the recordings (e.g., their names, their relation to each other). Combining widely known concepts (e.g., humans are superior to computers in processing voices and computers are superior to humans in handling data) expects to significantly enhance existing authentication methods (e.g., passwords, biometrics-based).

  • Open Access

    Characterizing and Quantifying Performance Heterogeneity in Cardiovascular Risk Prediction Models — A Step Towards Improved Disease Risk Assessment

    by Uri Kartoun, Shaan Khurshid, Bum Chul Kwon, Aniruddh Patel, Puneet Batra, Anthony Philippakis, Amit Khera, Patrick Ellinor, Steve Lubitz, Kenney Ng

    Prediction models are commonly used to estimate risk for cardiovascular diseases; however, performance may vary substantially across relevant subgroups of the population. Here we investigated the variability of performance and fairness across a variety of subgroups for risk prediction of two common diseases, atherosclerotic cardiovascular disease (ASCVD) and atrial fibrillation (AF). We calculated the Cohorts for Heart and Aging in Genomic Epidemiology Atrial Fibrillation (CHARGE-AF) for AF and the Pooled Cohort Equations (PCE) score for ASCVD in three large data sets: Explorys Life Sciences Dataset (Explorys, n = 21,809,334), Mass General Brigham (MGB, n = 520,868), and the UK Biobank (UKBB, n = 502,521). Our results demonstrate important performance heterogeneity of established cardiovascular risk scores across subpopulations defined by age, sex, and presence of preexisting disease. For example, in CHARGE-AF, discrimination declined with increasing age, with concordance index of 0.72 [ 95% CI, 0.72–0.73 ] for the youngest (45–54y) subgroup to 0.57 [ 0.56–0.58 ], for the oldest (85–90y) subgroup in Explorys. The statistical parity difference (i.e., likelihood of being classified as high risk) was considerable between males and females within the 65–74y subgroup with a value of -0.33 [ 95% CI, -0.33–-0.33 ]. We observed also that large segments of the population suffered from both decreased discrimination (i.e., <0.7) and poor calibration (i.e., calibration slope outside of 0.7–1.3); for example, all individuals 75 or older in Explorys (17.4%). Our findings highlight the need to characterize and quantify how clinical risk models behave and perform within specific subpopulations so they can be used appropriately to facilitate more accurate and equitable assessment of disease risk.


  • Top Cited Papers

    Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals

    by Aniruddh P. Patel, Minxian Wang, Uri Kartoun, Kenney Ng, Amit V. Khera

    Background: Individuals of South Asian ancestry represent 23% of the global population, corresponding to 1.8 billion people, and have substantially higher risk of atherosclerotic cardiovascular disease compared with most other ethnicities. US practice guidelines now recognize South Asian ancestry as an important risk-enhancing factor. The magnitude of enhanced risk within the context of contemporary clinical care, the extent to which it is captured by existing risk estimators, and its potential mechanisms warrant additional study. Methods: Within the UK Biobank prospective cohort study, 8124 middle-aged participants of South Asian ancestry and 449 349 participants of European ancestry who were free of atherosclerotic cardiovascular disease at the time of enrollment were examined. The relationship of ancestry to risk of incident atherosclerotic cardiovascular disease—defined as myocardial infarction, coronary revascularization, or ischemic stroke—was assessed with Cox proportional hazards regression, along with examination of a broad range of clinical, anthropometric, and lifestyle mediators. Results: The mean age at study enrollment was 57 years, and 202 405 (44%) were male. Over a median follow-up of 11 years, 554 of 8124 (6.8%) individuals of South Asian ancestry experienced an atherosclerotic cardiovascular disease event compared with 19 756 of 449 349 (4.4%) individuals of European ancestry, corresponding to an adjusted hazard ratio of 2.03 (95% CI, 1.86–2.22; P 2-fold higher observed risk, the predicted 10-year risk of cardiovascular disease according to the American Heart Association/American College of Cardiology Pooled Cohort equations and QRISK3 equations was nearly identical for individuals of South Asian and European ancestry. Adjustment for a broad range of clinical, anthropometric, and lifestyle risk factors led to only modest attenuation of the observed hazard ratio to 1.45 (95% CI, 1.28–1.65, P <0.001). Assessment of variance explained by 18 candidate risk factors suggested greater importance of hypertension, diabetes, and central adiposity in South Asian individuals. Conclusions: Within a large prospective study, South Asian individuals had substantially higher risk of atherosclerotic cardiovascular disease compared with individuals of European ancestry, and this risk was not captured by the Pooled Cohort Equations.